sees fy sales $4.9 billion to $5.3 billion.
sees fy adjusted earnings per share $2 to $2.20 excluding items.
sees q1 adjusted earnings per share $0.43 to $0.,0.50 excluding items.
q4 adjusted earnings per share $0.50.
q3 gaap earnings per share $0.49.
sees surgical structural heart sales in range of $800 million to $900 million for fiscal 2022.
sees q3 sales $3.2 billion to $33.6 billion.
sees full-year 2020 global sales of $762 million, down 10% on an underlying basis over prior year.